- The top 25 stories curated by editors and fellow readers!
From the Editor's Desk
Rooting for Them - Vulture (No paywall) Ben Affleck and Jennifer Lopez are keeping unapologetic, ostentatious celebrity romance alive.
Continued here
TradeBriefs: Newsletters for Decision-Makers!
|
WorkWork
WorkWork
WorkWork
WorkThe price war in weight-loss drugs is here - WSJ (No paywall) Eli Lilly and Novo Nordisk, the pharmaceutical heavyweights selling the popular injections, are each dangling discounts to gain an edge and to induce health plans to pay up. The concessions are slashing as much as half off the price tags of the $1,000-plus-a-month medicines. WorkHow the world's poor stopped catching up - The Economist (No paywall)SINCE THE Industrial Revolution, rich countries have mostly grown faster than poor ones. The two decades after around 1995 were an astonishing exception. During this period gaps in GDP narrowed, extreme poverty plummeted and global public health and education improved vastly, with a big fall in malaria deaths and infant mortality and a rise in school enrolment. Globalisation’s critics will tell you that capitalism’s excesses and the global financial crisis should define this era. They are wrong. It was defined by its miracles.
WorkWork
WorkHow the Next Generation of Managers Is Using Gen AI - Harvard Business Review (No paywall)Only 15% of managers consistently use gen AI, but 40% of business graduate students do. These managers and leaders of the near future will soon enter a workforce that is underprepared for them and poorly designed for them to put their abilities to use. This article explores how organizations should respond. Companies should learn to become a magnet for gen AI-savvy talent, and discover how to best onboard, engage, integrate, and retain the next generation of AI-capable managers. Work
WorkWorkThe Last Stand of the Rural Democrats - The New Yorker (No paywall)A summer heat wave had once again sped up the harvest in the Golden Triangle, a mostly flat, fertile pocket of land in Montana’s northern plains. In early August, Jon Tester, the state’s third-term senator, was home, at the end of a long unpaved road, tending to his wheat. Tester calls himself the only “working dirt farmer” in the Senate, and despite his critics’ belief that this is mostly performance, he does, in fact, continue to till the soil near the town of Big Sandy, where he has lived his entire life—and which his grandparents settled in following the Homestead Act of 1862, a giveaway of Indigenous land. Tester and his wife, Sharla, had recently bought some additional acres from their neighbors, Verlin and Patty Reichelt. “I just talked to him this morning next to his tractor,” Verlin told me. The Reichelts are recently retired wheat farmers and, like the Testers, part of a vanishing clan of rural Democrats.
WorkDemocracy Defenders11 people working to boost voter participation, reverse disenfranchisement, and combat misinformation Work WorkA Fungus Decimated American Bats. Now Scientists Are Fighting Back.But a decade later, her grief has turned into hope. Dr. Auteri and other researchers have made some crucial insights about how white-nose syndrome kills bats, and that knowledge has inspired a campaign to stop the mass death. Now, scientists are attacking the fungus and finding ways to help bats survive infections. WorkUAE hoping to expand $1 trillion partnership with U.S. through AI, InvestmentThe meeting of the two leaders also comes as the ongoing conflict in Gaza continues to cause a major humanitarian crisis and upend regional stability. The latest wave of Israeli attacks against Hezbollah targets in Lebanon and news that Iran is helping the Houthi rebels in Yemen to target and down U.S. Reaper drones has added to complications over a cease-fire, ahead of the anniversary of the Oct. 7 attack on Israel and the upcoming American election on Nov. 5. WorkWorkIsrael's Attacks on Hezbollah Intensify but Stop Short of All-Out WarIsrael has sabotaged Hezbollah’s communications devices, blowing up hundreds, if not thousands, of them in a widespread cyberattack. Its fighter jets have pounded southern Lebanon with rare intensity. And on Friday afternoon, they struck Beirut, the Lebanese capital, for the first time since July — killing a senior Hezbollah military commander, according to Israeli officials, and collapsing two buildings, according to Lebanese officials. WorkOpinion | The Trump Guide to Civil Discourse“Look,” his running mate, JD Vance, said on Monday, “we can disagree with one another, we can debate one another, but we cannot tell the American people that one candidate is a fascist and if he’s elected, it is going to be the end of American democracy.” (It should be noted that Vance has said repeatedly that he would have helped the former president in his attempt to overturn the results of the 2020 election.) WorkWorkWorkWorkA fear of dissent haunts the Federal Reserve - WSJ (No paywall) This week’s Federal Open Market Committee meeting is notable for two things. America’s central bank is shifting into monetary-easing mode amid considerable uncertainty about the true state of the economy, prospects for inflation and even the mechanisms by which Federal Reserve policy affects Main Street. And despite all these complex unknowns, almost everyone on the committee agrees. WorkWorkWorkRupert Murdoch's REA group ups offer for Rightmove to 5.9bnThe company is worth A$26bn and News Corp's overall digital real-estate services division, which includes operations in the US, accounted for a third of total global profits of $1.5bn in the year to the end of June. The Financial Times first reported the news of an increased offer for Rightmove by REA. WorkWorkWorkWorkWorkWorkWork'Super weird' is the best way to describe this startup's pivotSubscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. You also can follow Equity on X and Threads, at @EquityPod. For the full episode transcript, for those who prefer reading over listening, check out our full archive of episodes over at Simplecast. WorkLearn how to hire in 2025 at Disrupt 2024 | TechCrunchJoin these distinguished leaders speaking on the Builders Stage to gain invaluable insights into hiring and retaining top talent in 2025. This panel is a must-attend for founders looking to gain a competitive edge in the evolving startup landscape. Get your tickets now to save up to $600 during Reboot Week, and be a part of the conversation shaping the future of talent acquisition. WorkWorkWorkWorkWorkWorkCures for Sickle Cell Disease Arrive After a Painful Journey - Scientific American (No paywall)Nathan Wood is 15, lanky and tall. He longs to play basketball; he lives in Yonkers, just outside New York City, and his high school and city parks provide plenty of opportunity for shooting hoops. But his body won’t allow it. Nathan was born with sickle cell disease, an inherited condition that makes round red blood cells collapse into sticky crescents. The distorted cells clump inside blood vessels, depriving tissues of oxygen and inflicting excruciating pain. Exercise or stress or even just changes in routine can trigger a crisis, so Nathan’s mother, Melissa Wood, has often homeschooled him and drives him everywhere—a rare thing in New York, where kids prize their independence. WorkAmerica's looming election crisis, explained in 3 chartsThe US presidential campaign is in its final weeks and we’re dedicated to helping you understand the stakes. In this election cycle, it’s more important than ever to provide context beyond the headlines, but in-depth reporting is costly. To continue this vital work, we have an ambitious goal to add 5,000 new members. WorkEnvironmentalists Fear Subsidies for Carbon Capture Won't Be CheckedThe Treasury Department, which oversees the I.R.S., estimates the subsidies will cost the federal government more than $36 billion in revenue over 10 years. That is nearly as much as the cost of the tax program that allows some Americans to claim tax credits for their child-care expenses. WorkTrump's Suggestion That Jews Could Cost Him Race Creates Fear of Antisemitic Reprisal“Pre-emptively blaming American Jews for your potential election loss does zero to help American Jews,” Jonathan Greenblatt, the chief executive officer of the Anti-Defamation League, a Jewish-led human rights group, said on Friday in response to Mr. Trump. “It increases their sense of alienation in a moment of vulnerability when right-wing extremists and left-wing anti-Zionists continually demonize and slander Jews. Let’s be clear, this speech likely will spark more hostility and further inflame an already bad situation. ” WorkA G.O.P.-Linked Group's Contradictory Ads Cast Harris as Friend and Foe of IsraelMany Jewish Americans hold complex views about the war, which followed the Hamas-led attack on Israel on Oct. 7 and has resulted in tens of thousands of deaths in Gaza. But some have been troubled by what they see as disproportionate criticism of Israel on the left — and the Pennsylvania ad seems designed to play on those concerns. WorkIn Jan. 6 Case Filing, Trump Lawyers Again Demand DismissalAnd yet, as they have done in other cases Mr. Trump is facing, the lawyers sought to repurpose the filing to their client’s own ends, employing the same type of combativeness expressed by Mr. Trump in discussing the charges against him. WorkGeorgia Election Board Orders Hand-Counting of BallotsTo start hand-counting on election night, poll workers would likely have to break open the seals on boxes of completed ballots, possibly exposing the ballots to fraud or loss. In previous elections, ballots remain sealed and stored securely unless a recount was ordered. WorkNike is changing CEOs -- but analysts don't see a quick fixAs Hill steps into his new role on October 14, the stakes are high. Investors and analysts alike are closely watching to see if this leadership change can usher in the transformative strategies that Nike needs to regain its competitive edge. While the potential for turnaround exists, the road ahead will require careful navigation. WorkNovo Nordisk's experimental weight loss pill has some concerning side effects“The phase 2a results indicate the weight-lowering potential of monlunabant and that further work is needed to determine the optimal dosing to balance safety and efficacy,” said Martin Holst Lange, executive vice president and head of development at Novo Nordisk, in a statement. “Obesity is a complex disease with a significant unmet need, and as an oral small molecule having a new mechanism of action, monlunabant is one of the novel projects in our pipeline with the potential of treating obesity.” |
TradeBriefs Publications are read by over 100,000 Industry Executives About Us | Advertise | Privacy PolicyUnsubscribe (one-click) You are receiving this mail because of your subscription with TradeBriefs.
Our mailing address is 3110 Thomas Ave, Dallas, TX 75204, USA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|